Peking Union Medical College Hospital

This study looked at whether adding a third drug (fluzoparib) to a two-drug combination (apatinib and letrozole) helps control recurrent ovarian cancer longer. It included adults with a specific type of ovarian cancer that had responded to prior treatment. The study was stopped e…

This study looked at whether adding cyclosporine to rituximab works better than rituximab alone for treating a kidney condition called idiopathic membranous nephropathy. The trial planned to enroll many participants but was stopped early after only 12 people joined. The goal was …

This study tested whether a drug called roxadustat could prevent acute kidney injury in adults undergoing heart bypass surgery. The trial planned to enroll 98 participants but was terminated early. Researchers aimed to see if the drug, which helps tissues handle low oxygen, could…